LB-100 |
|||
B2031-25 | Biovision | EUR 588 |
Biovision Laboratories manufactures the biovision 104-100 reagents distributed by Genprice. The Biovision 104-100 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact BioVision. Other Biovision products are available in stock. Specificity: Biovision Category: 104-100
Etoposide (100 mM) |
||
Biovision | EUR 153 |
NE-100 hydrochloride |
||
Biovision | 1 mg | EUR 110 |
NE-100 hydrochloride |
||
Biovision | 5 mg | EUR 293 |
S-100 Blocking Peptide |
||
Biovision | EUR 153 |
PBS Tablets (100 ml) |
||
Biovision | EUR 164 |
ATP Solution (100 mM) |
||
Biovision | EUR 126 |
100 bp DNA Ladder |
||
Biovision | EUR 278 |
Triton® X-100 Solution (10% in H?O) |
|||
2104-100 | Biovision | EUR 137 |
LB-100 |
|||
B2031-25 | Biovision | EUR 588 |
LB-100 |
|||
B2031-5 | Biovision | EUR 185 |
S-100 Antibody |
|||
3958-30T | Biovision | EUR 146 |
Cycloheximide (100 mM) |
|||
1041-1 | Biovision | EUR 142 |
NE-100 hydrochloride |
|||
B3047-1 | Biovision | 1 mg | EUR 110 |
NE-100 hydrochloride |
|||
B3047-5 | Biovision | 5 mg | EUR 293 |
S-100 Blocking Peptide |
|||
3958BP-50 | Biovision | EUR 153 |
100 bp DNA Ladder |
|||
M1158-500 | Biovision | EUR 278 |
LB-100 |
|||
B4846-100 | ApexBio | 100 mg | EUR 860 |
AIM-100 |
|||
A3148-100 | ApexBio | 100 mg | EUR 1859 |
Description: AIM-100 is a small inhibitor of Ack1 tyrosine kinase with IC50 value of 24 nM [1]. AIM-100 mimicked ATP and inhibited the activity of Ack1 significantly and specifically. |
Triton® X-100 Detergent |
|||
B2394-1L | Biovision | EUR 262 |
Triton® X-100 Detergent |
|||
B2394-500 | Biovision | EUR 196 |
MTBK_20640-100 |
|||
AR02-P0011-100 | Abfrontier | 100ug | EUR 1133 |
hAlbumin FRET 100 |
|||
AH1005-100 | Mediomics | 1 Kit | EUR 212 |
hAlbumin TRF 100 |
|||
AHTR1005-100 | Mediomics | 1 Kit | EUR 239 |
hIgG TRF 100 |
|||
HITR1011-100 | Mediomics | 1 Kit | EUR 239 |